Tempest Therapeutics (TPST) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Tempest Therapeutics (TPST) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Tempest Therapeutics

· TPST

Dashboard

Financials

Ratios

Valuation

Statistics

13.686 M

+2.96%

General

Market Cap: $13.69M
Enterprise Value: $20.11M
Shares Outstanding: 15,980,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -420.14%
ROE: -1270.11%
ROIC: -628.18%
Current Ratio: 0.38
Debt-to-Equity: -6.94
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -0.50

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $18.46M
Operating Income: -$40.64M
Net Profit: -$40.47M

Balance Sheet

Cash and Equivalents: $779K
Working Capital: -$2.75M
Total Assets: $9.63M
Net Debt: $6.78M
Total Liabilities: $10.72M
Total Equity: -$1.09M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$20.73M
Cash Flow from Investing: —
Cash Flow from Financing: $7.23M
Free Cash Flow: -$20.73M
Capital Expenditures: $0